FDA Investigator Nerizza B Guerin

Nerizza B Guerin has inspections in 3 countries as of 26 Oct 2023. Nerizza B Guerin has collaborated with a combinined 4611 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
132
Last Inspection Date:
26 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, India, Mexico
Co-Investigator(s):
Addam S Reynolds, Adetutu M Gidado, Alan L Truong, Albert M Brindle, Alberto A Viciedo, Alice S Tsao, Amanda B Vega, Amy L Singer, Amy M Cramer, Amy W Yan Mai, Ana P Pineda Zavaleta, Ana S Cabrera, Anastasia I Offordile, Ankur C Patel, Ann Marie Montemurro, Annemarie B Randow, Annemarie Bodnar, Antoinette L Ravelli, Arindam Dasgupta, PhD, Ashutosh Rao, PhD, Atul J Agrawal, Barbara A Burke, Barbara D Wright, Barbara J Maulfair, Barbara J Wilimczyk, Barbara Jwilimczyk Macri, Bijoy Panicker, Brandon L Mariner, Brandy N Lepage, Brooke K Higgins, Brooke K Seeman, Byungja E Marciante, Byungja E Mercuente, Byungja H Marciante, Carole L Jones, Cary Greene, Cassandra L Abellard, CDR Kimberly Y Martin, Charanjeet Jassal, Charisse K Green, Charles M Spyr, Christina N Maurino, Christopher J Adams, Colleen F Hoyt, Daniel J Grabicki, David A Schwartz, David J Eide, David M Beltran, David R Delucia, Dawa L Wydner, Dawn C Olenjack, Dawn L Wydner, Dawn L Wyndver, Denise M Visco, Investigator, Dhaval H Patel, Diane M Gubernot, Diane T Bargo, Diane T O'brien, Donald C Obenhuber, PhD, Doreen P Gubbay, Dorothy J Denes, Douglas C Kovacs, Dr. Jason R Caballero, Dr. Robert C Horan, MD, Edward O'shaughnessy, Edward Oshaughnessy, Edwin Melendez, Eliezar Ramos, Emest F Bizjak, Emily A Walters, Emmanuel J Ramos, Eric Rothschild, Erma Zaimova, Esteban Beltran, Eufemia G Gonzalez, Ferderick Razzaghi, Frank J Marciniak, Frederick Razzaghi, Gam S Zamil, Gary J Lehr, Gary T Greco, Guerlain Ulysse, Harperd, Helen B Ricalde, Helen Verdel, Herrmann, Hitesh R Patel, Jacqueline A Shaughnessy, PhD, Jacqueline S Warner, James A Liubicich, James R Birkenstamm, James T Mccoy, Janet A Rajan, Jean M Kelahan, Jeanne D Shaffer, Jeffrey J Ebersole, Jennifer A Bazergui, Jennifer L Custodio, Jennifer Macmillan, Jessica M Monteiro, Jill M Sooter, Jo Annc Declement, Jogy George, Jonathan S Helfgott, Jonathan W Chapman, Jonee J Mearns, Jones, Jose M Cayuela, Joseph W Matthews, Jot R Klena, Joy Rkozlowski Klena, Juan Rjimenez Garcia, Juanita P Versace, Judith A Jones, Judith A Paterson, Justin A Boyd, Justin H Price, Justine Tomasso, Kara A Scheibner, PhD, Karen E D'orazio, Karen F Tomaziefski, Karen L Kosar, Karishma G Gopaul, Karishma Gopaul, Keith M Reilly, Kelli F Dobilas, Kelly I Anderson, Kelly L Anderson, King, Kinh Q Mac, Kip J Hanks, Kish Bolden, Kristy A Zielny, Kyle D Covill, Lata C Mathew, PhD, Lauren L Vajo, Laurissa S Flowers, Lawrence W Farina, LCDR Anastasia Mpiliafas Brown, Leigh Anne Myers, Lewis K Antwi, Li Li, Liatte Kreuger, PharmD, Lisa B Hall, Lisa Harlan, Lisa Mathew, Lisa P Oakes, Loretta Nemchik, Lori S Lawless, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marea K Harmon, Margaret M Sands, Margaret Sand, Margaret Torres Vazquez, Maria Estrella, Marion W Nadeau, Marjorie D Schultz, Martin K You, Melissa A Freeman, Melissa B Libby, Melissa J Garcia, Melissa T Roy, Meredith L Sheridan, Merideth K Rose, Meyer J Slobotsky, Meyer J Sobotsky, Meyer Slobotsky, Michael A Charles, Michael R Klapal, Michael Rosner, Michael Serrano, Michelle M Parisi, Mielziner, Mohsen Rajabi Abhari, FDA, Morea K Harmen, Mpris Inspector, Myra K Casey, Nancy F Scheraga, Nancy M Espinal, Nazmul Hassan, Neil J Bonzagni, PhD MPH, Nerizza B Dalena, Nerizza Dalena, Nicholas A Violand, Niketa Patel, Nikisha M Bolden, Nina D Patel, Nina Yang, Patricia A Morrow, Patrick C Klotzbuecher, Paul L Bellamy, Peter R Lenahan, Philip F Istafanos, DMV, MS, Rachel C Harrington, Rafael Nevarez Nieves, Randolph Campos Santiago, Raymond L Cheung, Rebecca Rodriguez, Regina T Brown, Richard D Manney, Richard J Bashay, Robert C Steyert, Robin P Mathew, Rose Ljean Mary, Rose M Ashley, Russell J Glapion, Russell P Vandermark, Samina S Khan, Samir C Gala, Sands, Sarah Forney, Satheesh K Podaralla, Satheesh Thomas, Schultz, Sean G Casey, Seng Ching Hwang, Sharon K Thoma, PharmD, Sherri J Liu, Shirley H Isbill, Shirley S Wen, Shirshendu K Deb, PhD, Shusheen A Alexander, Sinai Davis, Sony Mathews, State Agency, Stephanie Mangigian, MS/OSH, RN, Stephanie T Durso, Stephen D Brown, Stephen J Mottola, Steven M Weinman, Steven P Donald, Susan M Halsted, Susan M Joseph, Susant Hadman, Suzanne M Healy, Suzanne M Muchene, Tajah L Blackburn, Tanya R Syffrard, Tara G Bizjak, Tara R Gooen, Tawny L Colling, Terry Bridgewater, Thomas J Mooney, Tonia F Bernard, Tressa T Lewis, Tyanna N Hadley, Uduak M Inokon, Valerie C Reed, Valerie Reed, Victoria Spivak, Vipulchandr N Dholakia, Wanda Y Fields, Wanda Y Honeyblue, Wayne J Meyer, William J Leonard, William J Muszynski, William R Brubaker, William W Dotts, Xiaohan Cai, PhD

Nerizza B Guerin's Documents

Publish Date Document Type Title
November, 2002 FDA 483 Response Celerion - Form 483R, 2002-11-11
November, 2002 FDA 483 Celerion - Form 483, 2002-11-06
December, 2004 EIR Princeton Center for Clinical Research - EIR, 2004-12-13
December, 2022 EIR Interquim, S.A. de C.V. - EIR, 2022-12-16
June, 2023 FDA 483 Renaissance Lakewood LLC - Form 483, 2023-06-06
December, 2003 FDA 483 Musculoskeletal Transplant Foundation, Inc. - Form 483, 2003-12-10
April, 2003 FDA 483 Response Boghossian, Jack MD - Form 483R, 2003-04-09
February, 2004 FDA 483 Hunterdon Medical Center Blood Bank - Form 483, 2004-02-12
April, 2006 FDA 483 Vantage Specialty Ingredients, Inc - Form 483, 2006-04-07
February, 2004 EIR Hunterdon Medical Center Blood Bank - EIR, 2004-02-12
February, 2004 FDA 483 Response Hunterdon Medical Center Blood Bank - Form 483R, 2004-03-16
January, 2005 EIR Ohm Laboratories Inc. - EIR, 2005-01-18
March, 2002 EIR Syneos Health Clinical, Inc. - EIR, 2002-03-13
June, 2021 FDA 483 Bell-More Labs Inc - Form 483, 2021-06-07
January, 2005 FDA 483 Response Ohm Laboratories Inc. - Form 483R, 2005-02-01
August, 2009 EIR Curia New Jersey, LLC - EIR, 2009-08-05
November, 2002 EIR Celerion - EIR, 2002-11-06
July, 2021 FDA 483 Response LNK International, Inc. - Form 483R, 2021-07-23
June, 2023 EIR Renaissance Lakewood LLC - EIR, 2023-06-06
May, 2002 FDA 483 Sanofi-Aventis U.S. LLC - Form 483, 2002-05-20
November, 2004 FDA 483 Response Ohm Laboratories Inc - Form 483R, 2004-11-22
September, 2002 EIR Marchione, Victor MD - EIR, 2002-09-11
July, 2021 FDA 483 LNK International, Inc. - Form 483, 2021-07-01
April, 2003 EIR Boghossian, Jack MD - EIR, 2003-04-04
November, 2004 EIR Ohm Laboratories Inc - EIR, 2004-11-22
May, 2002 EIR Sanofi-Aventis U.S. LLC - EIR, 2002-05-20
May, 2018 EIR Rakshit Drugs Private Ltd - EIR, 2018-05-22
November, 2004 FDA 483 Ohm Laboratories Inc - Form 483, 2004-11-22
November, 2004 EIR OHM LABORATORIES INC. - EIR, 2004-11-23
April, 2003 FDA 483 Boghossian, Jack MD - Form 483, 2003-04-04
July, 2021 EIR LNK International, Inc. - EIR, 2021-07-01
March, 2008 FDA 483 Shore Institute For Reproductive Medicine, P.C. - Form 483, 2008-03-05

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more